Ocrevus and Cellulitis - a phase IV clinical study of FDA data
Cellulitis is found among people who take Ocrevus, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Ocrevus and have Cellulitis. It is created by eHealthMe based on reports of 35,378 people who have side effects when taking Ocrevus from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
35,378 people reported to have side effects when taking Ocrevus.
Among them, 324 people (0.92%) have Cellulitis.
What is Ocrevus?
Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 35,410 Ocrevus users for its effectiveness, alternative drugs and more.
What is Cellulitis?
Cellulitis (infection under the skin) is found to be associated with 3,018 drugs and 2,248 conditions by eHealthMe.
Number of Ocrevus and Cellulitis reports submitted per year:
Time on Ocrevus when people have Cellulitis *:
Gender of people who have Cellulitis when taking Ocrevus*:
Age of people who have Cellulitis when taking Ocrevus *:
Common drugs people take besides Ocrevus *:
Common side effects people have besides Cellulitis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Ocrevus and have Cellulitis?Check whether Cellulitis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
How severe was Cellulitis and when was it recovered:
Expand to all the drugs that have ingredients of ocrelizumab:
Alternative drugs to, pros and cons of Ocrevus:
- Ocrevus (35,410 reports)
Common Ocrevus side effects:
- Fatigue (feeling of tiredness): 5,313 reports
- Urinary tract infection: 3,631 reports
- Weakness: 3,150 reports
- Headache (pain in head): 2,813 reports
- Pain: 1,904 reports
Browse all side effects of Ocrevus:a b c d e f g h i j k l m n o p q r s t u v w x y z
Cellulitis treatments and more:
- Cellulitis (66,245 reports)
COVID vaccines that are related to Cellulitis:
- Cellulitis in Moderna COVID Vaccine
- Cellulitis in Pfizer BioNTech Covid Vaccine
- Cellulitis in Johnson and Johnson Covid Vaccine
Common drugs associated with Cellulitis:
- Prednisone: 5,344 reports
- Methotrexate: 4,308 reports
- Aspirin: 3,510 reports
- Humira: 3,005 reports
- Enbrel: 2,968 reports
- Lasix: 2,889 reports
- Furosemide: 2,688 reports
- Fosamax: 2,469 reports
- Metformin: 2,219 reports
- Omeprazole: 2,198 reports
All the drugs that are associated with Cellulitis:
- Cellulitis (3,018 drugs)
Common conditions associated with Cellulitis:
- Rheumatoid arthritis: 6,424 reports
- Multiple sclerosis: 3,251 reports
- Psoriasis: 2,980 reports
- High blood pressure: 2,973 reports
- Osteoporosis: 2,533 reports
- Pain: 2,287 reports
- Multiple myeloma: 2,176 reports
All the conditions that are associated with Cellulitis:
- Cellulitis (2,248 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ocrelizumab (the active ingredients of Ocrevus) and Ocrevus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tysabri and Red Man Syndrome - 7 seconds ago
- Erythromycin Ethylsuccinate and Glucophage drug interaction - 9 seconds ago
- Vimpat and Subdural Haemorrhage - 14 seconds ago
- Dermatitis Atopic Aggravated and Neuralgia - 19 seconds ago
- Exemestane and Hypervolaemia - 27 seconds ago
- Entecavir and Mefenamic Acid drug interaction - 28 seconds ago
- Prednisolone and Dental Care - 31 seconds ago
- Sumavel Dosepro and Alanine Aminotransferase Increased - 33 seconds ago
- Metrocream and Gilenya drug interaction - 35 seconds ago
- Penicillin and Pregnancy With Contraceptive Device - 39 seconds ago